94 related articles for article (PubMed ID: 9322442)
1. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858.
Sejbal J; Wang Y; Cann JR; Stewart JM; Gera L; Kotovych G
Biopolymers; 1997 Oct; 42(5):521-35. PubMed ID: 9322442
[TBL] [Abstract][Full Text] [Related]
2. An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions.
Sejbal J; Cann JR; Stewart JM; Gera L; Kotovych G
J Med Chem; 1996 Mar; 39(6):1281-92. PubMed ID: 8632435
[TBL] [Abstract][Full Text] [Related]
3. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
Miskolzie M; Gera L; Stewart JM; Kotovych G
J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
[TBL] [Abstract][Full Text] [Related]
4. New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor.
Monteagudo ES; Calvani F; Catrambone F; Fincham CI; Madami A; Meini S; Terracciano R
J Pept Sci; 2001 May; 7(5):270-83. PubMed ID: 11428548
[TBL] [Abstract][Full Text] [Related]
5. The importance of the N-terminal beta-turn in bradykinin antagonists.
Miskolzie M; Gera L; Stewart JM; Kotovych G
J Biomol Struct Dyn; 2000 Oct; 18(2):249-60. PubMed ID: 11089646
[TBL] [Abstract][Full Text] [Related]
6. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues.
Otter A; Bigler P; Stewart JM; Kotovych G
Biopolymers; 1993 May; 33(5):769-80. PubMed ID: 8393713
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
8. An NMR conformational analysis of cyclic bradykinin mimics. Evidence for a beta-turn.
Miskolzie M; Yamamoto H; York EJ; Stewart JM; Kotovych G
J Biomol Struct Dyn; 2000 Jun; 17(6):947-55. PubMed ID: 10949162
[TBL] [Abstract][Full Text] [Related]
9. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies of a bradykinin B1/B2 antagonist linked to a human neutrophil elastase inhibitor; a heterodimer for the treatment of inflammatory disorders.
Leimer AH; Kroona HB; Blodgett JK; Whalley ET; Ross SE; Burkard MR; Zuzack JS; Gernert DL; Dyckes DF
Can J Physiol Pharmacol; 1997 Jun; 75(6):633-8. PubMed ID: 9276141
[TBL] [Abstract][Full Text] [Related]
11. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
Fathy DB; Kyle DJ; Leeb-Lundberg LM
Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
[TBL] [Abstract][Full Text] [Related]
12. Membrane-induced secondary structures of neuropeptides: a comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor.
Whitehead TL; McNair SD; Hadden CE; Young JK; Hicks RP
J Med Chem; 1998 Apr; 41(9):1497-506. PubMed ID: 9554882
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors.
Hess JF; Hey PJ; Chen TB; O'Brien J; Omalley SS; Pettibone DJ; Chang RS
Biol Chem; 2001 Jan; 382(1):123-9. PubMed ID: 11258662
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance studies of bradykinin antagonists.
Liu X; Stewart JM; Gera L; Kotovych G
Biopolymers; 1993 Aug; 33(8):1237-47. PubMed ID: 8364157
[TBL] [Abstract][Full Text] [Related]
15. Backbone structure confirmation and side chain conformation refinement of a bradykinin mimic BKM-824 by comparing calculated (1)H, (13)C and (19)F chemical shifts with experiment.
Wang B; Miskolizie M; Kotovych G; Pulay P
J Biomol Struct Dyn; 2002 Aug; 20(1):71-80. PubMed ID: 12144353
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of new linear and cyclic bradykinin antagonists.
Thurieau C; Félétou M; Hennig P; Raimbaud E; Canet E; Fauchère JL
J Med Chem; 1996 May; 39(10):2095-101. PubMed ID: 8642569
[TBL] [Abstract][Full Text] [Related]
17. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
Morissette G; Bouthillier J; Marceau F
Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profiles of the human and rabbit B1 receptors.
Gobeil F; Neugebauer W; Nguyen-Le XK; Nea Allogho S; Pheng LH; Blouin D; Whalley ET; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):591-5. PubMed ID: 9276134
[TBL] [Abstract][Full Text] [Related]
19. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
20. Novel pseudopeptides with high affinities for the human bradykinin B2 receptor.
Chakravarty S; Connolly M; Kyle DJ
Pept Res; 1995; 8(1):16-9. PubMed ID: 7756750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]